SCHEMBL38203

SCHEMBL38203

[CH]=CC/C=C/C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL38204 1.00
SCHEMBL2551469 0.94
SCHEMBL2551472 0.94
SCHEMBL27531668 0.88 TSHR (0.32)
SCHEMBL29284464 0.82 ALDH1A1 (0.32)
SCHEMBL4099962 0.82 TRPV1 (0.39)
SCHEMBL28730970 0.82 ALDH1A1 (0.39)
SCHEMBL4099959 0.82 TRPV1 (0.39)
SCHEMBL27713832 0.78
SCHEMBL29284344 0.78 TRPV1 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3513 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1000070-B1 SILICON-CONTAINING CHAIN EXTENDERS AORTECH BIOMATERIALS PTY LTD (AU) 2003-09-10 EP claimed
EP-0984997-B1 SILICON-BASED POLYCARBONATES AORTECH BIOMATERIALS PTY LTD (AU) 2002-09-18 EP claimed
EP-0823254-B1 NOVEL USE OF PYRAZOLOPYRIDINE COMPOUNDS FUJISAWA PHARMACEUTICAL CO (JP) 2002-07-17 EP claimed
US-6420452-B1 POLYURETHANES WITH EXTENDERS AORTECH BIOMATERIALS PTY LTD (AU) 2002-07-16 US claimed
JP-51118788-A None JP disclosed
US-12042479-B2 Use of topical formulations of cannabinoids in the treatment of epidermolysis bullosa and related connective tissue disorders INMED PHARMACEUTICALS INC. 2024-07-23 US disclosed
US-20240239762-A1 NOVEL HETEROCYCLIC COMPOUNDS FLORATEK PHARMA S A (CH) 2024-07-18 US disclosed
US-20240239751-A1 PROCESSES FOR PREPARING AG-10, ITS INTERMEDIATES, AND SALTS THEREOF BRIDGEBIO GENE THERAPY RESEARCH, INC. 2024-07-18 US disclosed
US-20240238427-A1 METHODS OF TREATING AN EYE DISORDER KODIAK SCIENCES INC. 2024-07-18 US disclosed
US-20240239807-A1 SARS-COV2 MAIN PROTEASE INHIBITORS GILEAD SCIENCES, INC. 2024-07-18 US disclosed
CN-118344348-A Heterocyclic substituted quinazoline and preparation method and application thereof 苏州泽璟生物制药股份有限公司 2024-07-16 CN disclosed
CN-118324767-A Diacylglycerol kinase modulating compounds 卡尔那生物科学株式会社 2024-07-12 CN disclosed
US-4289778-A SYSTEMIC INSECTICIDES ELI LILLY AND COMPANY (US) 1981-09-15 US disclosed
EP-0034249-A2 New naphthimidazole and naphthoxazole derivatives, their preparation, and their use in pharmaceuticals GRUPPO LEPETIT S.P.A. (IT) 1981-08-26 EP disclosed
US-4195092-A INSECTICIDES FOR TREATING MEXICAN BEAN BEETLE ELI LILLY AND COMPANY (US) 1980-03-25 US disclosed
EP-0003081-A2 Thiazolidinecarbothioamides, their preparation, compositions and use as insecticides ELI LILLY AND COMPANY (US) 1979-07-25 EP disclosed
EP-0002939-A2 Novel carbothioamides, compositions containing them and their preparation ELI LILLY AND COMPANY (US) 1979-07-11 EP disclosed
EP-0002938-A2 Novel heterocyclic carbothioamides, compositions containing them, their preparation and use ELI LILLY AND COMPANY (US) 1979-07-11 EP disclosed
JP-S51118788-A METHOD FOR SYNTHESIZING NOVEL PENICILLIN DERIVATIVES YAMANOUCHI PHARMACEUT CO LTD 1976-10-18 JP disclosed
US-3971825-A (5,6) (10,11) BIS-METHYLENE, BRONCHODILATORS SANKYO COMPANY LIMITED (JA) 1976-07-27 US disclosed